The loss of AMPK signal transduction can enhance oncogenic drivers such as LKB1, TSC2, and P53, thereby promoting cell growth, proliferation, and the reprogramming of cancer cell metabolis [34, 35]. This evidence concerns the gene TP53 and cancer.